Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.
BACKGROUND
Patients with cystic fibrosis periodically experience pulmonary exacerbations. Previous studies have noted that some patients' lung function (FEV(1)) does not improve with treatment.


OBJECTIVE
To determine the proportion of patients treated for a pulmonary exacerbation that does not recover to spirometric baseline, and to identify factors associated with the failure to recover to spirometric baseline.


METHODS
Cohort study using the Cystic Fibrosis Foundation Patient Registry from 2003-2006. We randomly selected one pulmonary exacerbation treated with intravenous antibiotics per patient and compared the best FEV(1) in the 3 months after treatment with the best FEV(1) in the 6 months before treatment. Recovery to baseline was defined as any FEV(1) in the 3 months after treatment that was greater than or equal to 90% of the baseline FEV(1). Multivariable logistic regression was used to estimate associations with the failure to recover to baseline FEV(1).


RESULTS
Of 8,479 pulmonary exacerbations, 25% failed to recover to baseline FEV(1). A higher risk of failing to recover to baseline was associated with female sex; pancreatic insufficiency; being undernourished; Medicaid insurance; persistent infection with Pseudomonas aeruginosa, Burkholderia cepacia complex, or methicillin-resistant Staphylococcus aureus; allergic bronchopulmonary aspergillosis; a longer time since baseline spirometric assessment; and a larger drop in FEV(1) from baseline to treatment initiation.


CONCLUSIONS
For a randomly selected pulmonary exacerbation, 25% of patients' pulmonary function did not recover to baseline after treatment with intravenous antibiotics. We identified factors associated with the failure to recover to baseline, allowing clinicians to identify patients who may benefit from closer monitoring and more aggressive treatment.
Sanders
Don B
DB
Department of Pediatrics, American Family Children's Hospital, 600 Highland Avenue, Madison, WI 53792-9988, USA. dbsanders@pediatrics.wisc.edu
Bittner
Rachel C L
RC
Rosenfeld
Margaret
M
Hoffman
Lucas R
LR
Redding
Gregory J
GJ
Goss
Christopher H
CH
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology*; D018450:Disease Progression; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D007262:Infusions, Intravenous; D016015:Logistic Models; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D055815:Young Adult
D000900:Anti-Bacterial Agents
Am J Respir Crit Care Med. 2010 Sep 1;182(5):627-32
20463179
Pediatr Pulmonol. 2007 Jun;42(6):525-32
17469153
Eur Respir J. 2005 Nov;26(5):948-68
16264058
Am J Respir Crit Care Med. 2001 May;163(6):1331-7
11371397
Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8
19729669
Am J Respir Crit Care Med. 2008 Oct 15;178(8):814-21
18669817
Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
9872837
Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1550-5
12406843
Chest. 2002 Jan;121(1):64-72
11796433
Chest. 2007 Aug;132(2):562-8
17646236
Pediatr Pulmonol. 2010 Feb;45(2):127-34
20054859
Pediatr Pulmonol. 2009 May;44(5):464-71
19360849
Pediatrics. 1999 Jun;103(6):e72
10353969
J Pediatr. 2006 Feb;148(2):259-64
16492439
Thorax. 2007 Apr;62(4):360-7
17387214
Am J Respir Crit Care Med. 2006 Dec 1;174(11):1211-20
16959918
Pediatr Pulmonol. 2005 Jul;40(1):39-44
15858802
Adv Data. 2000 Jun 8;(314):1-27
11183293
J Pediatr. 2007 Aug;151(2):134-9, 139.e1
17643762
J Pediatr. 1997 Dec;131(6):809-14
9427882
N Engl J Med. 1996 Jul 18;335(3):179-88
8657217
Am J Epidemiol. 2001 Feb 15;153(4):345-52
11207152
Pediatr Pulmonol. 1993 Dec;16(6):347-53
8134156
Am J Respir Crit Care Med. 2003 Dec 15;168(12):1471-5
12969869
J Pediatr. 1999 Apr;134(4):413-21
10190914
Pediatr Pulmonol. 1993 Feb;15(2):75-88
8474788
Pediatr Pulmonol. 2003 Jul;36(1):43-8
12772222
Chest. 2003 Jan;123(1):20-7
12527598
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):891-5
10988101
Chest. 2003 May;123(5):1495-502
12740266